Regulatory Guidance updates 1st September to 9th October 2026 – ERA have tracked them for you! HPRA (IE): HPRA Strategic Plan 2026–2029 sets out priorities & direction for the next four years HPRA has arranged a MedSafety Week to take place between the 2–8 November 2026 International Coalition of Medicines Regulatory Authorities (ICMRA) has […]
Recognizing our commitment to pharmaceutical regulatory excellence, client partnerships and delivering practical solutions for the pharmaceutical industry. We are delighted to announce that ERA has been shortlisted for the Waterford Business Awards 2026 – a significant milestone for our team and a proud moment for our business. The shortlist recognizes the hard work, dedication and […]
Title: Regulatory Guidance updates in August 2026. Body text: Regulatory Guidance updates in August 2026 – ERA have tracked them for you! HPRA (IE): Updated HPRA Guide to the Clinical Trials Regulation to reflect the full implementation of the Clinical Trials Regulation (CTR) to align with current European and national guidance and best practices […]
Regulatory Guidance updates in July 2026 – ERA have tracked them for you! HPRA (IE): The SoHO Regulation: all you need to know to get started guideline was published by the HPRA Are you involved in activities concerning Substances of Human Origin (SoHO) intended for human applications? Are you a facility where SoHO are applied […]
Regulatory Guidance updates in June 2026 – ERA have tracked them for you! HPRA (IE): HPRA webinar – There was a webinar held on the 19th June 2026 on recent updates and developments in the veterinary medicine regulation A recording should be made available in due course Guidance on “Submitting a Request for a New […]
![ICH image - Generated by AI [Copilot]](https://eureg.ie/wp-content/uploads/2026/06/ICH-M4Q-R2-image-v1-10-06-26-Copilot-300x197.png)
ICH M4Q(R2), “The Common Technical Document for the Registration of Pharmaceuticals for Human Use” is a revised draft version of the guidance that outlines how the quality sections of your medicinal product dossier are presented. ICH M4Q(R2) was signed off as a Step 2 document in May 2025. Public consultation closed in October 2025. In […]
Did you know that the following Regulatory Guidance was updated in May 2026? HPRA (IE): Promoting medicines to the public on social media – the HPRA has launched a new webpage, setting out clear information on the laws that apply to advertising human medicines for the public HPRA webinar – There will be a webinar […]
Did you know that the following Regulatory Guidance was updated in March and April 2026? HPRA (IE): HPRA guidance issued in relation to EMA list of ingredients restricted or prohibited for use in cosmetics from 1st May 2026 CTCG Guidance and Webinar: New Article 11 Workaround for Clinical Trials: The Clinical Trials Coordination Group (CTCG) […]
![Feature Image [CoPilot]](https://eureg.ie/wp-content/uploads/2026/04/Feature-Image-CoPilot-300x200.png)
So what is a Post Approval Change Management Protocol (PACMP) The post approval change management protocol (PACMP) was introduced in the EU through the European Commission Guidelines on variation categories. It is a regulatory tool which allows the management of specific quality change(s) in a more predictable and efficient manner, during the lifecycle of a […]
Let’s get Back to Basics – Biological Medicines According to Part I of Annex I of Directive 2001/83/EC, a biological medicinal product is a product that contains a biological substance. A biological substance is a substance that is produced by or extracted from a biological source and that needs for its characterisation and the determination […]
Here are the main highlights of Regulatory Guidance updated in February 2026 HPRA (IE): The HPRA promoted the Facilitating and Accelerating Strategic Clinical Trials (FAST-EU). FAST-EU is a pilot initiative aiming to accelerate the assessment and authorisation of clinical trials running in multiple EU/EEA countries. The pilot is currently open for submissions and is expected […]
Were you aware that the following Regulatory Guidance was updated in January 2026? HPRA (IE): Updated fee guidance document for Human medicinal products MHRA (UK): The MHRA have been very busy updating their website in January – here are some of the highlights Medicines: International Recognition Procedure Updated dates indicating the submission deadlines for […]
Dungarvan Enterprise Centre,
Fairlane Roundabout
Dungarvan,
Co. Waterford,
Ireland.
X35 FC60